Bcl-x(L) promotes metastasis of breast cancer cells by induction of cytokines resistance

Cell Death and Differentiation

Volumn 7, Issue 4, 2000, Pages 350-359

  Fernandez Y ^a   Espana L ^a   Manas S ^a   Fabra, A ^a   Sierra, A ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Apoptosis; Bcl x(L); Breast cancer; Cytokines; Metastasis

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; PROTEIN BCL X; SCLEROPROTEIN; BCL2L1 PROTEIN, HUMAN; BCL2L1 PROTEIN, MOUSE; PROTEIN BCL 2; RECOMBINANT PROTEIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL ADHESION; CELL SURVIVAL; CONTROLLED STUDY; DNA TRANSFECTION; HUMAN; HUMAN CELL; LUNG; METASTASIS POTENTIAL; PRIORITY JOURNAL; SOUTHERN BLOTTING; ANIMAL; BREAST TUMOR; CELL CULTURE; CELL DIVISION; DRUG RESISTANCE; FEMALE; GENETIC TRANSFECTION; GENETICS; METABOLISM; METASTASIS; MOUSE; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; XENOGRAFT;

ANIMALIA;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; BREAST NEOPLASMS; CELL ADHESION; CELL DIVISION; CELL SURVIVAL; CYTOKINES; DRUG RESISTANCE, NEOPLASM; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; MICE; MICE, NUDE; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT PROTEINS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0033625203     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400662     Document Type: Article

References (30)

1. Nikiforov MA, Kwek SSS, Mehta R, Artwohl JE, Lowe SW, Gupta TD, Deichman GI and Gudkov AV (1997) Suppression of apoptosis by bcl-2 does not prevent p53-mediated control of experimental metastasis and anchorage dependence. Oncogene 15: 3007-3012
2. Holmgren L, O'Reilly MS and Folkman J (1995) Dormancy of micrometastatses: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med. 1: 149-153
3. L promotes susceptibility to mutagenesis. Oncogene 13: 1489-1497
4. Rudin CM and Thompson CB (1997) Apoptosis and disease: regulation and clinical relevance of programmed cell death. Ann. Rev. Med. 48: 267-281
5. Kroemer G (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med. 3: 614-620
6. Newton K and Strasser A (1998) The Bcl-2 family and cell death regulation. Curr. Opin. Genet. Dev. 8: 68-75
7. Chao DT and Korsmeyer SJ (1998) Bcl-2 family: regulators of cell death. Annu. Rev. Immunol. 16: 395-419
8. Boise LH, González-García M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nuñez G and Thompson CB (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608
9. L inhibits Ara-C-induced mitochondrial loss of cytochrome c and other peturbations that activate the molecular cascade of apoptosis. Cancer Res. 57: 3115-3120
10. L regulates the membrane potential and volume homeostasis of mitochondria. Cell 91: 627-637
11. L interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc. Natl. Acad. Sci. USA 95: 4386-4391
12. L protects cancer cells from p53-mediated apoptosis. Oncogene 11: 1389-1394
13. Olopade OI, Adeyanju MO, Safa AR, Hagos F, Mick R, Thompson CB and Recant WM (1997) Overexpression of Bcl-x protein in primary breast canceris associated with high tumor grade and nodal metastases. Cancer J. Sci. Am. 4: 230-237
14. 1 ductal breast carcinomas. Int. J. Cancer 79: 103-110
15. 1 breast cancer. Clin. Cancer Res. 2: 1887-1894
16. Sierra A, Castellsagué X, Escobedo A, Lloveras B, García-Ramirez M, Moreno A and Fabra A (2000) Bcl-2 with loss of apoptosis allows an accumulation of genetic alterations: a pathway to metastatic progression in human breast cancer. Int. J. Cancer 89: (in press)
17. Shtivelman E (1997) A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma. Oncogene 14: 2167-2173
18. Takaoka A, Adachi M, Okuda H, Sato S, Yawata A, Hinoda Y, Takayama S, Reed JC and Imai K (1997) Anti-cell death activity promotes pulmonary metastasis of melanoma cells. Oncogene 14: 2971-2977
19. Glinsky GV and Glinksy VV (1996) Apoptosis and metastasis: a superior resistance of metastatic cancer cells to programmed cell death. Cancer Lett. 101: 43-51
20. Sierra A, Price JE, García-Ramirez M, Mendez O, López L and Fabra A (1997) Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells. Lab. Invest. 77: 357-368
21. Arteaga CL, Dugger TC and Hurd SD (1996) The multifunctional role of transforming growth factor (TGF)-βs on mammary epithelial cell biology. Breast Cancer Res. Treat. 38: 49-56
22. Reisss M and Barcelos-Hoff MH (1997) Transforming growth factor-β in breast cancer: a working hypthesis. Breast Cancer Res. Treat. 45: 81-95
23. 2 in breast carcinoma cells. Oncogene 10: 2297-2305
24. L functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells. J. Biol. Chem. 20: 4523-4529
25. L expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor. Proc. Natl. Acad. Sci. USA 94: 5067-5072
26. Yawata A, Adachi M, Okuda H, Naishiro Y, Takamura T, Hareyama M, Takayama S, Reed JC and Imai K (1998) Prolonged cell survival enhances periotoneal dissemination of gastric cancer cells. Oncogene 16: 2681-2686
27. Del Bufalo D, Biroccio A, Leonetti C and Zupi G (1997) Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line. FASEB J. 11: 947-953
28. Vakkala M, Lähteenmäki K, Raunio H, Pääkkö P and Soini Y (1999) Apoptosis during breast carcinoma progression. Clin. Cancer Res. 5: 319-324
29. Zhang RD, Fidler IJ and Price JE (1991) Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invas. Metast. 11: 204-215
30. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-cloroform extraction. Anal. Biochem. 162: 156-159